Avasimibe, an inhibitor of cholesterol esterification enzyme, significantly empowers the anti-tumor response of CD8+ T cells, and its combination with anti-PD-1 antibody has a better efficacy in melanoma [13]. Here, PDCD1 is linked to neoplasm.